SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (ME), a leading genetic health and biopharmaceutical company, today launched 23andMe+ Total Health, its new, ...

Add Yahoo as a preferred source to see more of our stories on Google. Genetic testing company 23andMe, once valued at $6 billion, has filed for bankruptcy. State attorneys general are urging concerned ...

Regeneron Pharmaceuticals on Monday announced plans to purchase genetic testing company 23andMe for $256 million. The New York-based drugmaker is set to take over 23andMe after winning a bankruptcy ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...

23andMe helped 15 million users around the world answer the question we all share: Where did I come from? Since its launch in 2006, the biotechnology company has not only answered questions about ...

Regeneron Pharmaceuticals, a company that has been analyzing genetic data as part of its drug research for more than a decade, is augmenting its capabilities in a big way with the $256 million ...

From the San Francisco Business Times: An investment firm believes it can make financial lemonade out a soured 23andMe asset if a U.S. Bankruptcy Court judge approves the sale of telemedicine company ...

Regeneron Pharmaceuticals, a biotechnology company with a long history of large-scale genetics research, plans to buy DNA testing firm 23andMe out of bankruptcy, announcing Monday it was named the ...

Add Yahoo as a preferred source to see more of our stories on Google. May 2—The fate of more than 15 million customers' genetic data remains in limbo after popular DNA testing company 23andMe filed ...

Regeneron Pharmaceuticals announced on Monday that it will acquire "substantially all" of genetic testing company 23andMe's assets. The pharmaceutical company said it won the court-supervised auction ...